Clinical Trial

Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma

Name: Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular Carcinoma — clinical trial record (NCT07761286)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is an open-label, multicenter Phase Ib/II clinical study designed to evaluate the safety, tolerability, and efficacy of combination therapy with SYS6090 Injection in participants with hepatocellular carcinoma (HCC).

Trial Details

NCT Number	NCT07761286
Lead Sponsor	CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions	HCC - Hepatocellular Carcinoma
Enrollment	288 participants
Start Date	2026-09-30
Primary Completion	2029-09-30 (estimated)
Study Completion	2031-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-12